Burlington, MA (PRWEB) March 13, 2013
Formedix is launching a series of learning webinars focusing on the everyday issues affecting those within the clinical trial industry including Clinical Data Managers, Standards Directors and Biostatisticians.
On March 14, 2013, Kevin Burges, Technical Business and Standards Director (the company’s very own “Standards Guru”) and CEO, Mark Wheeldon will address questions frequently asked of Formedix regarding Define.xml, combined with real world knowledge and expertise.
- Creating and re-using Proprietary, CDISC SDTM and ADaM dataset libraries with Define
- Define-XML: The Myths and the Realities. Your Clinical Trials Automated. Everywhere.
- Study Start-up: Define-XML aided CRF design & specification process optimization
- Study Conduct and Analysis: Automated dataset validation with Define.xml
- The role of Define-XML in Legacy and Proprietary EDC dataset conversions
- Define-XML 2.0 enhancements: What do they mean to you?
-Define-XML 2.0 enhancements: Technical Deep Dive.
During the webinar, Mark Wheeldon and Kevin Burges will uncover the mystery of this CDISC standard, cover practical uses for Define in the course of an end-to-end clinical trial and, attendees will also have the opportunity to ask questions of the experts at Formedix.
Formedix’s Mark Wheeldon comments that “often Define is ‘churned out’ at the far end as a last gasp submission deliverable and very few people think of managing libraries of all their dataset designs upfront in this vendor neutral standard, or producing detailed dataset specifications for sharing internally or with CROs.” Mr Wheeldon continues, “It is a constant battle to remove the thought of Define as just a submission deliverable. Define-XML creation is becoming more complex and more difficult to produce a
Page: 1 2 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”2
. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 20123
. Discovery Labs to Report Fourth Quarter 2012 Results and Hold Conference Call on Wednesday, March 13, 20134
. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology5
. UCSB physicists make discovery in the quantum realm6
. Scientists discover molecule that does double duty in stopping asthma attacks7
. AMRI Promotes Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia8
. Discovery Labs Receives $30 Million Funding Commitment from Deerfield Management9
. Chicago to Welcome Data Science, Big Data and Data Mining Leaders at the 19th International ACM Knowledge Discovery and Data Mining Conference, KDD 201310
. Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX4011
. Discovery in synthetic biology takes us a step closer to new industrial revolution